Philips Biosensor BX100. a

Royal Philips has had its “Biosensor BX100” FDA approved for detecting COVID-19, based on monitoring heart beat and respiration rate.  “The lightweight, disposable biosensor is a 5-day, single-use wearable patch which can be integrated with a scalable hub to monitor multiple patients across multiple rooms. Built to incorporate into existing clinical workflows for mobile viewing and notifications, the device requires no cleaning or charging. The medical-grade wireless wearable biosensor, intended for use by healthcare professionals on patients 18 years of age and older, adheres discreetly to the chest to collect, store, measure and transmit respiratory rate and heart rate every minute – the top two predictors of deterioration – as well as contextual parameters such as posture, activity level and ambulation.” MORE

Image Credit: Royal Philips